137 related articles for article (PubMed ID: 9783492)
1. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
J Hum Hypertens; 1998 Sep; 12(9):627-9. PubMed ID: 9783492
[TBL] [Abstract][Full Text] [Related]
2. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
[TBL] [Abstract][Full Text] [Related]
3. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
4. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Chalmers J; Neal B; MacMahon S;
J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
[TBL] [Abstract][Full Text] [Related]
5. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
6. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
Ratnasabapathy Y; Lawes CM; Anderson CS
Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
[TBL] [Abstract][Full Text] [Related]
7. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS.
PROGRESS Management Committee
J Hypertens Suppl; 1996 Sep; 14(2):S41-5; discussion S45-6. PubMed ID: 8934377
[TBL] [Abstract][Full Text] [Related]
9. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
[TBL] [Abstract][Full Text] [Related]
10. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
Chalmers J; MacMahon S
J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
[TBL] [Abstract][Full Text] [Related]
11. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
[TBL] [Abstract][Full Text] [Related]
12. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
[TBL] [Abstract][Full Text] [Related]
13. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in patients 80 years of age or older.
Beckett NS; Peters R; Fletcher AE; Staessen JA; Liu L; Dumitrascu D; Stoyanovsky V; Antikainen RL; Nikitin Y; Anderson C; Belhani A; Forette F; Rajkumar C; Thijs L; Banya W; Bulpitt CJ;
N Engl J Med; 2008 May; 358(18):1887-98. PubMed ID: 18378519
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
Scheen AJ
Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395
[TBL] [Abstract][Full Text] [Related]
16. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure].
Lenders JW; Thien T
Ned Tijdschr Geneeskd; 2002 Mar; 146(9):398-9. PubMed ID: 11901939
[TBL] [Abstract][Full Text] [Related]
17. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
18. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.
Padma MV; Kaul S
Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
Chalmers J; Castaigne A; Morgan T; Chastang C
J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
[TBL] [Abstract][Full Text] [Related]
20. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
